Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023
By AP News - Apr 20, 2023, 04:09 PM ET
Last Updated - Jun 22, 2023, 05:17 AM EDT
TEMPLE CITY, Calif.--(BUSINESS WIRE)--Apr 20, 2023--
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that it will release its first quarter 2023 financial results before the market opens on Friday, May 5, 2023. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the results and answer questions.
The call may be accessed through a live audio webcast on the Investor Relations section of the company’s website, http://ir.fulgentgenetics.com. An audio replay will be available at the same location.
About Fulgent
Fulgent is a technology-based company with a well-established clinical diagnostic business and a therapeutic development business. Fulgent’s clinical diagnostic business offers molecular diagnostic testing services, comprehensive genetic testing, and high-quality anatomic pathology laboratory services designed to provide physicians and patients with clinically actionable diagnostic information to improve the quality of patient care. Fulgent’s therapeutic development business is focused on developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company aims to transform from a genomic diagnostic business into a fully integrated precision medicine company.
View source version on businesswire.com:https://www.businesswire.com/news/home/20230420005846/en/
CONTACT: Investor Relations Contact:
The Blueshirt Group
Melanie Solomon,melanie@blueshirtgroup.com
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL ONCOLOGY HEALTH HEALTH TECHNOLOGY GENETICS
Sponsored
SOURCE: Fulgent Genetics, Inc.
Copyright Business Wire 2023.
PUB: 04/20/2023 04:05 PM/DISC: 04/20/2023 04:05 PM
http://www.businesswire.com/news/home/20230420005846/en
Sponsored
Read More from Press Releases
Popular News
Latest News
